Estudio en EEUU

Fallo en operar el cáncer pancreático en estadio temprano

Los pacientes con cáncer de páncreas en estadio temprano -sin ninguna contraindicación identificable- el 38,2% fracasó en ser sometido a cirugía.

Autor/a: Dres. Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS.

Fuente: Ann Surg 2007; 246(2): 173-180

Indice
1. Bibliografía
2. Desarrollo

1. American Cancer Society: Cancer Facts and Figures. Available at http://www.cancer.org/docroot/stt/stt_0.asp . Accessed December 15, 2006.
2. Brennan MF. Adjuvant therapy following resection for pancreatic adenocarcinoma. Surg Oncol Clin N Am. 2004;13:555-566, vii.
3. Stojadinovic A, Hoos A, Brennan MF, Conlon KC. Randomized clinical trials in pancreatic cancer. Surg Oncol Clin N Am. 2002;11:207-229, x.
4. Conlon KC, Klimstra DS, Brennan MF. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg. 1996;223:273-279.
5. Fernandez-del Castillo C, Rattner DW, Warshaw AL. Standards for pancreatic resection in the 1990s. Arch Surg. 1995;130:295-299, discussion 299-300.
6. Richter A, Niedergethmann M, Sturm JW, et al. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg. 2003;27:324-329.
7. Schmidt CM, Powell ES, Yiannoutsos CT, et al. Pancreaticoduodenectomy: a 20-year experience in 516 patients. Arch Surg. 2004;139:718-725, discussion 725-727.
8. Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg. 2000;4:567-579.
9. Whipple AO. An evaluation of radical surgery for carcinoma of the pancreas and ampullary region. Ann Intern Med. 1949;31:624-627.
10. Cameron JL, Riall TS, Coleman J, Belcher KA. One thousand consecutive pancreaticoduodenectomies. Ann Surg. 2006;244:10-15.
11. Lieberman MD, Kilburn H, Lindsey M, Brennan MF. Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg. 1995;222:638-645.
12. Riall TS, Nealon WH, Goodwin JS, et al. Pancreatic cancer in the general population: improvements in survival over the last decade. J Gastrointest Surg. 2006;10:1212-1223, discussion 1223-1224.
13. Winchester DP, Stewart AK, Bura C, Jones RS. The National Cancer Data Base: a clinical surveillance and quality improvement tool. J Surg Oncol. 2004;85:1-3.
14. International Classification of Disease for Oncology. 2nd ed. Geneva: World Health Organization, 1990.
15. International Classification of Disease for Oncology. 3rd ed. Geneva: World Health Organization, 2000.
16. AJCC Cancer Staging Manual. 6th ed. Chicago, IL: Springer, 2002.
17. Standards of the Commission on Cancer Volume II: Registry Operations and Data Standards. Vol. II: Commission on Cancer, 1998.
18. Facility Oncology Registry Data Standards. Chicago: Commission on Cancer, 2004.
19. Department of Health and Human Services. The International Classification of Diseases. 9th revised. Clinical modification: ICD-9-CM. Washington, DC: Government Printing Office, 1998.
20. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
21. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
22. Commission on Cancer: Approvals Categories. Available at http://www.facs.org/cancer/coc/categories.html . Accessed December 17, 2006.
23. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
24. Cox D. Regression models and life tables. J R Stat Soc. 1972;34:187-220.
25. United States Census Bureau. Census 2000. Available at http://www.census.gov/main/www/cen2000.html . Accessed January 21, 2007.
26. Fong Y, Gonen M, Rubin D, et al. Long-term survival is superior after resection for cancer in high-volume centers. Ann Surg. 2005;242:540-544, discussion 544-547.
27. Sener SF, Fremgen A, Menck HR, Winchester DP. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg. 1999;189:1-7.
28. Bilimoria K, Bentrem D, Ko C, et al. Multimodality therapy for pancreatic surgery in the United States: utilization, outcomes, and the effect of hospital volume. 2006. Submitted for publication.
29. Baxter NN, Whitson BA, Tuttle TM. Trends in the treatment and outcome of pancreatic cancer in the United States. Ann Surg Oncol. 2007;14:1320-1326.
30. Eloubeidi MA, Desmond RA, Wilcox CM, et al. Prognostic factors for survival in pancreatic cancer: a population-based study. Am J Surg. 2006;192:322-329.
31. Lucas FL, Stukel TA, Morris AM, et al. Race and surgical mortality in the United States. Ann Surg. 2006;243:281-286.
32. Sohn TA, Yeo CJ, Cameron JL, et al. Should pancreaticoduodenectomy be performed in octogenarians? J Gastrointest Surg. 1998;2:207-216.
33. Makary MA, Winter JM, Cameron JL, et al. Pancreaticoduodenectomy in the very elderly. J Gastrointest Surg. 2006;10:347-356.
34. Cameron JL, Pitt HA, Yeo CJ, et al. One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg. 1993;217:430-435, discussion 435-438.
35. Afsari A, Zhandoug Z, Young S, et al. Outcome analysis of pancreaticoduodenectomy at a community hospital. Am Surg. 2002;68:281-284, discussion 284-285.
36. Bilimoria K, Bentrem D, Ko C, et al. Validation of the AJCC Staging System for Pancreatic Cancer. Cancer. 2007. In press.
37. Birkmeyer JD, Stukel TA, Siewers AE, et al. Surgeon volume and operative mortality in the United States. N Engl J Med. 2003;349:2117-2127.
38. Birkmeyer JD, Warshaw AL, Finlayson SR, et al. Relationship between hospital volume and late survival after pancreaticoduodenectomy. Surgery. 1999;126:178-183.
39. Birkmeyer NJ, Goodney PP, Stukel TA, et al. Do cancer centers designated by the National Cancer Institute have better surgical outcomes? Cancer. 2005;103:435-441.
40. Finlayson EV, Goodney PP, Birkmeyer JD. Hospital volume and operative mortality in cancer surgery: a national study. Arch Surg. 2003;138:721-725, discussion 726.
41. Gordon TA, Bowman HM, Tielsch JM, et al. Statewide regionalization of pancreaticoduodenectomy and its effect on in-hospital mortality. Ann Surg. 1998;228:71-78.
42. Sosa JA, Bowman HM, Gordon TA, et al. Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg. 1998;228:429-438.
43. Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. JAMA. 1998;280:1747-1751.
44. Ayanian JZ, Zaslavsky AM, Fuchs CS, et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol. 2003;21:1293-1300.
45. Bickell NA, Chassin MR. Determining the quality of breast cancer care: do tumor registries measure up? Ann Intern Med. 2000;132:705-710.
46. Cress RD, Zaslavsky AM, West DW, et al. Completeness of information on adjuvant therapies for colorectal cancer in population-based cancer registries. Med Care. 2003;41:1006-1112.
47. Malin JL, Kahn KL, Adams J, et al. Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst. 2002;94:835-844.
48. Hawker GA, Coyte PC, Wright JG, et al. Accuracy of administrative data for assessing outcomes after knee replacement surgery. J Clin Epidemiol. 1997;50:265-273.
49. Henderson T, Shepheard J, Sundararajan V. Quality of diagnosis and procedure coding in ICD-10 administrative data. Med Care. 2006;44:1011-1019.
50. Kahn LH, Blustein J, Arons RR, et al. The validity of hospital administrative data in monitoring variations in breast cancer surgery. Am J Public Health. 1996;86:243-245.